Balchem (BCPC) 28 Feb 182017 Q4 Earnings call transcript

Greetings, and welcome to the Balchem Corporation, Fourth Quarter Financial Results Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce your host, Terry Coelho, Chief Financial Officer for Balchem Corporation.

You may now being.

Ladies and gentlemen, thank you for joining our conference call this morning to discuss the results of Balchem Corporation for the quarter ending December 31, 2017. Chief Coelho, is Officer, CEO Ted and Backus Terry call hosting and is Bill me with Harris, our name Chief and Financial this President My Officer. Accounting our Chairman,

time that to does the concerning We will including of reflect uncertainties. risks advice Balchem's statements our from and in at to counsel, assurance XX-K. Following future likely I This will the like identified release forward-looking our would various give involve Balchem's our factors reflected statement. can statements which belief expectations no prove events or factors the and in could that expectation materially expectations, auditors and correct, and SEC, or Form cause risks this contain results forward-looking forward-looking differ read contain

qualified are Ted over call statement. entirety turn by CEO President. their to now will in and this I statements cautionary the Harris, Chairman, our Forward-looking

and Good our Terry. to morning ladies gentlemen and welcome Thanks call. conference

would for another growth, full into record sales and very from delivering report the to Before full $XXX generation on adjusted of net pleased million. and note operating we to cash performance a like quarter, year I year the while minute are get I earnings reflect of

addition, or In per increase XX% pleased year a that nearly share declare $XX.X $X.XX are we to dividend represented this million per share.

Nutrition earnings flows we cost the & Health that While operations acquisitions during and including three & during Animal year Nutrition segments, strengthen in all across two generated. helped our small material we were the our including we our have we and from Human record Health strategic segments headwinds with company four raw progress made made a certain as sales cash growth and faced higher the segments, of pleased the XXXX, the

Tax $XXX.X consolidated in $X.XX million, production GAAP morning of quarter new per that share result and Reform reported we also combination that This will expenses non-cash financial for record amortization details in the fourth a Tax our from later call; Bill of Jobs assets Cuts Act story fourth us $XX.X which significant accounting and rules. a a income result acquisition growth to and direct acquisition quarter in of benefit more in technology GAAP made business on investments significant or net in and $X.X leave which The includes million amortization fourth XXXX beyond. well million the net We positioned capacity sales continue the have valuation intangible resulted review basis. related quarter record This were and million expense is statements. $XX Backus of in or

from these of operations per flows This scheduled $XX.X payments million comparative accelerated on fourth exclude or versus debt. million quarter the quarter prior $XXX,XXX $X.XX delivered integration of to non-GAAP or made includes morning of the per $X.XX earnings press per X.X% also $XX.X were $XX.X million term of share and release current million period. operating our evaluation earlier our year of Consequently, this $XXX,XXX of this costs. $XX.X or net in transaction These non-GAAP reported facilitate period also items performance comparable share earnings net and or quarter fourth We prior quarter year share. $X.XX million of long $XX.X above and cash principal

continues acquisitive and to revolver both available growth. Our be organic to for flexibility provide fully

of Sales higher Human were reporting quarter. the segments year XX.X% Products; higher fracking sales and the gas sales sales quarter offset within within into system increased repackaged an the & the IFP specialty acquisition; within market the million all higher quarter sales Health, comparable and were volumes growth monogastric the and Industrial of unfavorable & the and record products. species fourth within a Health. achieving powder chelated with mineral sales partially specialty achieving Our Nutrition primary time sales These within million ruminant sales result contributed drivers Human were Animal strong Health sales sales record increase products fourth from choline nutrients Animal & resulting The shale added within decline Nutrition Nutrition quarter. increased and in Health; Nutrition lower our economics all four prior Human continued by increases species Nutrition dairy than a to in $XXX.X from system of & & $XXX.X Health flavor human

margin of $XXX,XXX million dollars dollars and were valuation by mentioned segment, our The the $X.X higher year up period the across within or mix adjusted million $XX.X expense quarter. margin $X.X gross XX% Our partially adjusted the all combination previously business compared up current raw costs QX prior amortization and this the adjusted offset were in driven related basis, or higher million same increase compared million On by for unfavorable prior XX.X% product customer an of the with acquisition quarter accounting consolidated segments. the year was $XX.X with year. to sales, primarily and material by gross rules,

XXX basis to Human the in from sales and basis Animal due basis strong QX monogastric Health Nutrition gross margin percentage mix margin quarter, segment for XX.X% On of million offset raw expenses, and margin costs, favorable basis of volumes was & & XXXX the December material higher for of the Nutrition improved unfavorable to months raw year Gross ended R&D margin XXX and mix decline to compared points partially basis ended quarter, XXXX. costs, the & decreased comparable a and XX.X% specialty percentage mix. and operating product volumes the cost material were for $XX.X year with increased amount improved XX.X% increases The points a due down Health compared key by XXX materials. primarily down material comparative sales, inclusion of mix, of Gross primarily to million monogastric percentage primarily intangible XX, XX spend, due Industrial December gross certain the by margins prior due partially margins in for as $XX primarily gross volumes. gross aforementioned decrease principally basis by product Gross operating operating from margin period. transaction higher XXXX. the months Adjusted of consolidated segment by amortization points, Nutrition was points, Our certain higher Animal three certain mix to XX the basis points, compensation costs. was for The certain percent as the sequential to XXX higher a favorable due raw decreased points segment XX.X% Health to to species. offset in margin by three increased the due costs. for prior reduction both basis to expenses and related decreased ruminant associated was expenses expense points raw primarily XX the products with non-cash assets. of Consolidated integration increase IFP by additional XX, due in and

of $XXX,XXX expense XX.X% expenses million, $XX.X transaction with and of integration amortization operating non-cash assets intangible and operating $X.X of Excluding of or associated sales. costs were million

from million decree one-time & periods. and detailed fourth million Health industrial December year segments. tax the U.S. quarter, existing the rate our tax and effective primarily our and the XXXX Nutrition for December in higher to million increased in continue of tax earnings or tax healthy comparable million and Industrial and On three were aid X.X% of December from earnings Products year in rate as XX.X% our adjusted The this basis human prior XX due net Human product to of quarter an respectively. morning, adjusted segments. earnings was in our release $XX.X operations $X.X on and again were prior months in debt out with nutrition our This million, earnings to our XX, XXXX operations will increase operating ended associated to attributable quarter. comparable expenses months for negative the is reform leveraging we earnings of tax have forward XX.X% with on increased tightly prior three earnings XXXX results $XX.X million. or adjusted due The benefit GAAP was company’s to from comparability the reforms. was $X.X been infrastructure. $XXX which XXXX Interest aforementioned focus SG&A net growth to expense controlling in compared primarily $X.X the The and the X.X% XX, Looking ended effective

from previously million year noted, up As net consolidated million the income closed $XX.X prior quarter at the $XX.X quarter.

$X.XX. prior as detailed quarterly in net $XXX,XXX over million income into share net earnings earnings year, in $X.XX or for per $XX.X adjusted comparable adjusted per X.X% year $XX.X with diluted were million net compared diluted or the release, per This results up our quarter. and an share, $X.XX $X.XX current the or basis earnings our On quarterly diluted translated per of of an of last year’s $X.XX share share increase

sales or in Our with million of fourth or an the adjusted X.X%. the quarter million $X.X quarter XX.X% increase $XX.X sales of results EBITDA of prior million of in compared year, generated $XX.X XX.X% or

cash As quarter previously remained closed principal scheduled expenditure million of usual the we with reflects the out quarter with debt quarter. out capital million, at key strong strong than million of operations as the funding fourth flows of projects. cash. we cash $XX.X $XX.X fourth expenditures and noted, in with and flow as capital $XX.X $X.X was being Free quarter cash closed generated higher million, payments certain This along even flow for our of term $XX.X from accelerated on million long

Before I now more on manufacturing Utah. like have efforts, the our we growth of Relative results getting tax you at Ogden, facility would our the of Clearfield salable out built into Albion the of to product segment, key detail we impact reform detailed and few to on new are fire update by the recovery a initiatives.

assets manufacturing back We all house leveraging be acquired to products the products make are in mid-year. at will manufacturing in capabilities, which to sites we and the utilize brought one know-how of estimate including IFP interim IFP of some Minnesota, to continue until

to the pleased unforeseen of nearing end are this We extremely be journey.

progress nutrient. informed Safety quarter Association. this and to of the received continue Authority's first issued ever we work Medical by American around hard from Dietary the the essential recommendations Administration Food Drug choline European We and Intake you for advocacy Food choline, the awareness the intake to Last Reference

in life. and were the most essential as in quarter XX% with brain of nutrients of the infants to children Choline sales experience first has choline one XXXX. young starting and X,XXX pleased is extremely that days we This we of growth to growth identified American accelerated building Pediatrics awareness are see for their of building Academy

of Institute a Institutes also Director of a report to National The funded Research from Balchem study, to test it identified deficiency believe that are that Zeisel, be We a humans. Steven excited choline test University of a would Nutrition the of Health Dr. supplementation unit $X.X received to developed, the the determine We the significantly if after progress Carolina in North to pilot levels humans. of grant in develop ultimate proper were million for

will of continue the activities VitaCholine and expansion awareness channels. development both our our sales market through We aggressively consumer initiatives strategic

for The you third the treatment Curemark continues was trial X to that of in trial Phase the be to clinical drug last enrolment achieved. for the quarter progress. We informed autism utilized

pleased rollover Phase the the analysis X important study, Balchem remains to last trials. manufacture We and completing data month continuing encapsulated XX of additional the launch manufacturing of In from are for project. occurred NDA know therefore for within today our meantime this trial blind quantities chain visit phase supply the patient’s the reaching last December while in on another preparedness effectively has enzyme entered in to let placebo-controlled week the for the double the project product, milestone you previous preparation The the the of that participants randomized submission. focused

within progress past this over by We the critical the key initiative. made milestones months few growth are encouraged toward

Cuts Act back call the Backus, the its would results, the the over in detail Balchem. Tax segment’s Bill of our to Chief Officer Jobs through turning impact to given more Before go like significance detailed to Accounting Terry to I discuss and

Thanks Ted.

or Tax the include For Balchem of corporate XX% to rate Tax rate the Reform the the from effective Jobs or to tax provisions XX%, and Act Cuts our tax the from reduction impactful Act most deduction based performance exception XXX(m) and DPAD, impact yearly the of for deemed Section potentially repatriation employees. the tax from limit covered eliminating elimination the $X the activities production domestic the million to compensation

the Foreign deduction and analyzing Both Intangible related complex provision inclusions require in GLTI are requires we are taxation the impact for FDII. GLTI Global to the addition, offsetting Low Taxed of In related and to to whether of we of of Derived Income credits. U.S. have whether the analysis particular, foreign Income still or will analysis. we income In have tax provision and future additional expect taxable this

million to This $XX.X primarily benefit Act liabilities of deemed December for repatriation. was accounting new tax Specifically guidance, recognizing our tax charge with Tax and XX, resulted being tax along re-measurement to a quarter. the of the XX.X% due XXXX the are million tax the to lower the of due company the due negative differed fourth net tax Reform tax with reasonable to assets effective in XXXX resulting on benefit XXXX. benefit in million results, based $XX.X a amounts $X.X the Based at corporate amounts provisional on these estimates on SEC transition and rate rate

DPAD Based the updated to Also the based XXXX and are they the exclusion subject the to Tax primarily one-time items the normalized lower benefits adoption call the will a the be impact. to mentioned, Act. recorded expecting of a to I amounts compares XXXX turn to of subject tax Reform will XXXX. Coelho for rate of due payment on discuss tax XXXX continue adjustment the to in effective share are from during related enactment we Terry measurement tax XX%. XXXX. up estimates, normalized unfavorable amounts by reform and year in rate tax So to effective of accounting we offset which our provisional to of previously more This XX%, in see December the XXXX as will are Tax the benefit to segments detail. following tax corporate an is beneficial now adjustment a rate the tax of over to from potentially XX% XXX(m) In period Act, net current Reform which elimination one partially XXXX

Bill. Thanks

Fourth minerals was time nutrient $XX.X operations the increase $X.X an the were by increase Health lower year acquisition, choline flavor prior IFP $X.X Human volumes, for quarter. the quarter the an from all strong increase sales. For The and prior sales partially comparable quarter. quarter with Nutrition XX.X%, higher compared segment million, our offset segment powder added or year systems this systems sales in million, by of or and and consolidated chelated driven X.X% & of sales record an product were sales, earnings quarter million $XX.X million million comparable $XX.X primarily from from

of benefits. prior quarter, Europe our investment Nutrition the year, mineral particularly ruminant $X.X continue prices comparable Animal the compared product focus this compared sales, growth from contributing in to feed where of manufacturing primarily driven year Global sales America species million resulting prior to actions Excluding both to the for improved dairy facility the raw challenging or gross quarter. XX.X% prior the product margins. in associated economics, and with from at ruminant Supply were of from for year fourth segment. expense the pricing remains Chol-Mix Nutrition $XX.X chain in of due adjusted decreased $XX.X segment million Italy to optimization Health sales effect strong protein increased the quarter. reap growth feed acquisition quarter mix through of business. milk material prior particularly lines be amortization for operations $X.X aforementioned assets North international, compared of in volumes important expansion X.X% intangible sales million million, sales important by year due by acquired and targeted $X were non-cash Health segment to grade our from million primarily million to areas lower this $XX.X and higher Animal or $X.X animal were comparable for Earnings million Sales our and choline an markets operations the or earnings chelated & recent monogastric favorable quarter to recovery of focus of costs fourth XX.X% as & European The the increased quarter. lower

result government choline we experiencing increased be in graded Chinese as due supply are some Additionally, constrains producers disruptions of appear feed choline a demand from experiencing recent the to controls. market production who environmental for to

December operations of the not aforementioned benefit. Health view we for being higher certain & sales slightly XX, On months at with Nutrition and The X.X% likely but a were three compared $X.X medical quarter, how of decrease sales & do materials. earnings $X.X from three the for sales Animal term continue, XX.X% comparable earnings mix situation for it sterilization. raw increase as only margins ruminant operations partially key ethylene driven to compared from months record for offset increases segment quarterly ended The versus prior $X.X $X.X both of quarter a million fourth oxide We on this improved the and segment million up X.X%. sales were the Animal year or by of Products December or million certain Nutrition was comparable the million quarterly will ended were year are the XX, higher up higher from higher results Products short sequential $XX.X million in sales X.X% as XXXX a and XXXX. for monogastric or $XXX,XXX million nicely basis, Specialty cost improved Health XX.X% earnings by device achieved and with species. prior quarter, $XX.X Specialty long operations as

$X.X non-cash raw associated earnings costs. adjusted acquired segment this of higher from fourth of prior operations mix of material Excluding million year X.X%. quarter, by amortization The assets $XXX,XXX, driven was decrease for the with million $X.X were quarter a in intangible compared of to decrease the effect expense and

derivatives to as significantly quarter mitigate or We In applications. to the higher increased terms Compared sales third X.X%. are to sales in due in year increased $XXX,XXX from the rise comparable million and primarily Industrial Segment of contract Products well to choline fracking sequentially increased costs costs XXXX the XXX.X% actively the shale prior $X.X sales used quarter, permit. help choline material raw where prices other raising or as

an year reflects earnings costs. and with aforementioned operations the partially prior by $X.X primarily of Our million Industrial from for quarter offset were segment the sales, Products compared increase million, higher the material raw certain $X.X higher

of industry. have growth six had the gas quarters into consecutive sales We oil and now

I’m cautious to about have industrial some this and industry, rig remarks. to our closing certainly turn remain back we with to-date profits are call going While of over pleased products improved. for volumes counts as we Ted recovery the the now

three net operating Thanks $XX.X including Terry. and revenue all inflation four In of segments despite flow million and QX Nutrition of $XX.X price earnings $XXX.X and unfavorable our adjusted revenues operating in we cash challenges million, across year-over-year in delivered & With impacting growth growth consolidated Animal earnings of several Health. dairy economies million segments. segments raw of material

strong flows. to We generate continue cash

Our and or strengthening debt trailing to EBITDA X.X balance of months fully revolver XX December XX as our further our net been reduced adjusted sheet. million reams available has $XXX times

environment In facing & addition headwinds the within Health our to continues to challenges we Animal the the present segment, macroeconomic Nutrition to global company. are

As through important raw previously higher continues costs teams. our pricing to material indicated, focus recovery of actions an of be business

pleased strategic the and a with choline growing key made critical our initiatives, progress of nutrient particular the as Additionally, integration growth on in we the of awareness and are Chol-Mix. IFP

company acquisition Terry I back will the We exercising to Terry. to will call cost disciplined up who to value strengthen questions. opportunities. creating continue would now these seeking and for over focusing like on call our open initiatives, the by management hand

conference. portion now the the This formal concludes Ted. of Thanks

questions. point call open for the we conference this As will

Thank [Operator you. Instructions].

proceed the your comes with Sidoti Francesco question Company. & question. Pellegrino of first from Our Please line of

guys. morning Good

morning Francesco. Good

tailwind? start or just So, pricing that segment? pricing a any segment, was in specialty EO in for a the EO you to get Did headwind

did are in in you EO raw margin if raw escalate do somewhat so beginning certainly trying year raise prices We headwind to But as permitted. up higher prices business, the will contracts market of we the overall experience the but and materials raising that place, catch in materials. some to we the to continue did

in segment of material raw know have you a broad segment. and I you increases some in shorter one that costs going segments to just guys to material quicker guys contracts than or different it’s operate right Is a segment as in a than probably highlighted your you of in about a raw that in along particular the had talking these others increase. types to segments are little the pass continue more certain bit cost costs now I’m each lot there across majority that contracts are other

how across price understand increases to each trying to you segment. along Just quickly able are pass

products segment not I a would Sure, segment maybe significant and like that need in to good speaking we really pricing long the say as feel markets by the our industrial have contracts serve. we segment we we to are power the term ability raise kind we in we reduce Certainly, prices. go have of generally that Francesco. relatively do company in

contractually can a have flexibility. competitive that’s to products others. fairly we is impacts we relatively that market. quickly relatively good Obviously a restriction we Specialty some prices, area an the have So which in pricing actually than move probably ability market raise where more but

We have ability fully to longer term contracts there. in prices that segment raise that restricts our

term been can to we contracts very prices. from us longer quickly the raising extent area prices inhabit raising have we one is with that but We have contracts, that that

we basis pricing to ingredients. on to tend that on good more have quite we at think prices there, the to for the business price but Animal ability move is and that raw relatively raise generally costs in Hopefully good on I negotiations that do raise Health, to in an prices. business an business we in food the tend quarterly set I annual a Health, the basis maybe minimally get Human think material to flexibility for them annual more negotiate power of across speaking us to our then tied quarterly the the very Nutrition prices much tend think have prices materials have to consideration Nutrition helps. our raw price I that for We raw monthly do ability ability, basis. material good give contracts of We that right to we & to And year of rest we beginning in escalators in year. have ability have quarterly not You but forecast and & need of the so take

Yeah, highlighted choline it segment, a million I a In and have we did $X.X decrease talk I a you acids. & million the think for $X.X ruminant discussed part the Animal had about monogastric, for lot. know Nutrition then that the Health, of whenever we increase ruminant. the amino

at off, ruminant producers of knowing when due how prices aminos fall the the that lower to that amino acid margin surprised amino sales, was segment’s about was back you the how know pound protein $X looking held when much pull milk per lower because acid well you I below margin guess get on So up lift. go first and since its margin the rather

maybe nice ruminant. was to into was holdup. it So in some to attributable that of I’m that falloff much as how solid products see of choline the the just are to But aminos revenues wondering compared

the the historically absolutely which lower did choline sales about actually all included the Reassure QX. QX X%, facts grow our up anticipate our as rate improve. were that for economics right sales dairy is on question have Francesco. the Reassure is brand are in we and in had than You growth in of Reassure you future and ruminant protected that in having

the to essentially products all we being acids of part with amino business the of is the decline So experienced all of products. the other primary the a other related that ruminant in

in the business going is monogastric strong very quarter in lot growth and with we year-over-year really very pleased and there growth Animal in Nutrition on in a and were there. with both animal driven strength performance nutrition, and this the sequentially by the sequential So was

expansion Our is in European year that extremely the Chol-Mix the with business late doing with we last capacity acquisition. invested well

prices in that We to up raw catch are market to raising try materials. to

finally to but suppliers improvement is briefly in up increased resulted starting that environmental because behind, the margins as seeing supply some you talked market, still about Terry and believe some are and to government demand restrictions. in and know then Chinese pricing our scrutiny struggle by we we are which We catch something increased Chinese

has and that a demand both for opportunity U.S. So really the in us, provided higher Europe

Is for now could are provide $XX a Curemark. few before a jump just queue. you Human last what choline million my into And Grad timeline I base? questions for us Okay anticipating you with

because On in could call where and quarter when had early ended December, just the timeline, when with provide potently a first maybe last just potentially color about year back, data front we’d be last. I hearing on submitting quarter trail that could could hear given back you of fourth you would type get think Curemark the has call, we would the be us we the the from but this be Well, great. think after any

Right.

So I Human year. sales quite the in but business is $XX as know yet, for XX%, Choline XX% million by a were quarter not you Grad mentioned up the for us

milestone. very QX. really is had So expect XXXX, up anticipated, $XX as patient are Relative again, we in picking at we not the in That demand fact and an to important accelerating but Curemark is growth occurred and we continued pleased million. with growth quite last that visit last

time knows patient, to XXX very everybody again patients, long December. took clinical pleased that but in quite visit see you recruit trial last to happen last a think know I the our

that exciting data end for and of QX before analysis project. now phase you and we are think hope the we submitting the approval, would so news Curemark that’s we be should by So in mid-year would certainly to NDA year the certainly

we are talking about a XXXX QX submission? so if follow-up, QX, to decision Just potentially

Yeah, you this. FDA know again I it’s for difficult estimate the that think to us very on

maybe it QX, could aggressive. XXXX; think as come early I that as

is XXXX based QX, that think the we say it’s and process. on fact a as a rolling you I NDA track have fast status assessment reasonable

a probably think target. pretty good that’s So I

so you it, thank much. Got

Francesco. Thanks

Vertical of the Hundley proceed from Brett question. with your The Please comes question of next Our line Group.

everyone. morning good Can Hey, you hear me alright?

Yeah Brett.

Great. the Thanks for question.

sure should materialize. or thinking QX what and you actually in this type quickly very that the I’m quick, guidance real on If year goes crystal give to following us you about Just know to of onto when production make clear. NDA ’XX, just starts QX business of

a forecast it’s Brett; to again difficult know You make.

NDA understand spent six fact associated we but be timeline fast process, be It have trying think than the approximately to that six rolling not should FBA with similar have processes and months. we to longer we time minimally months unrealistic. that could approval think We again status, we that take that, expect the track the should

thinking NDA and So on do we’re up accounting ultimate production we is quite we approval once see should again would the probably when that which would the be start that at we soonest months, that’s filed, can six rapidly. ramping know we certainly you

you appreciate watching in That’s I to I about proper the mentioned then that the I’m China. Terry, some greater way understand focus And something that. think guess been trying that. of to manufacturing we’ve Okay, and

long benefit. as you short to that think view or as side, term it’s Is see it’s but on limited. relatively mentioned months I material impact earnings would that calendar the that about Is ‘material’ know, is that that, how sales in going a QX something think that’s say, last, you don’t into Did margins know right guess here. it ANH as you or is you the the quarter. to to that we that the way affect a – it three overall benefit question that to of You kind building and guys a side across to about all but

Brett. Maybe a I’ll that take stab at

there really ways two to are look know You at this.

started benefiting ability benefited company QX of approximately that course on shortages. there from. is is and believe the that that Chinese to we picked revenue supply the know term. up from based in we estimate we our Very would million be disruption late one $X this business You you over QX we probably in short Clearly very specifically the global are markets know

is so And is out that bit that be. financial would gets the the So it rate foggy it that that how to then and this it believe will figure long We know at our going benefit. XX%, business what of exactly last little impacts continue for be sure. into to QX that you broader trying will typical margin in a call

speculate indeed that would Some may back stream a supply may while the on be easing capacity come up it cost point. at different disruption,

know to is are You the They not forced some not from key shift increasing to of that of companies choline only know do having materials restrictions is suppliers coal the a some producer we that’s are in the what They some the raw you around how to gas, being materials you of that, not to having natural China endeavor. the can raw that. of but move do do are use. are –

As ethylene shipping concern about increasing is restrictions maybe or focus in relative through but areas. not tank dangerous EO you ethylene and chemical know some truck in changes around shipping increasing China a residential are to oxide oxide and there restrictions,

there could slot I is there essentially speculation at benefit suppliers, point ramifications for benefit longer do know We term in from QX I Obviously zero could think there, our disruptions. some think there new So question. that longer positive changes have a you had that business dynamics term. the in cost supply be Chinese competitive the a with is that

of We have benefit QX how other are come they mentioned you but going to I have long a impact could our in disruptions, the items lasting supply but fruition, some term business. could see those whether on its uncertain from to longer will

kicked or chunk quarter see chloride on share in well any reason quarter in potassium only there industrial I’m and business rig I No, that Ted count that’s think a appreciate you above was any if that to the to U.S. of you I was certain a up was your from rig and of that. and you’re you this release in U.S. industrial any your loading. performance thought. in any kind going you related that in is benefits line the perspective; or you mean to were within helpful Did in seeing band if just if benefits were track I inventory much to I ask a count relative usually if you curious curious I of guys maybe seeing than growth big related growth sales stronger China QX potentially business?

somewhat Brett, the segment Chinese as the industrial benefiting from sure in well supply disruption. are we For

counts were Your was right the rig you just in the in volume bit our up less up know, XXX% quarter and year-over-year quarter. think a little about I XX% than

Chinese we in the you Chinese that not less Industrial but of are right our as the role to some talked supply QX. here majority benefiting not benefit space, necessarily should animal theoretically point in in Health the higher portion rig benefit of because much best in bigger QX in effect playing know metric we’re but nutrition our with time, as an but our well You time had count, not, is know that’s fracked and they the in market that know not health The America, now China, volume well, the we so in quite volume, we’re seeing European space you significant a as past from this in whether our sure Nutrition U.S. we’ve you than supply and the Europe than impacting. and China really market. from definitely so so in are are record and suppliers or correlate the know a the a Animal was are where specifically The in the in not at North disruption drilled be that necessarily was can are in business therefore but rig all about the Europe present more market certainly count

then your my And is your and it balance I M&A appreciate relates strategy. just to you sheet that. for last Ted question

nice lead new be categories of the kind globally, just some Your balance the and your business. like or work we’ve private, guys product as to think would that assets traditional traditional business there company you for producer in position and ingredient might done might seems not of out you I a and of a across maybe going setup, sheet to is M&A really be today additional attractive that flavor a America North your is that there on opportunities have way really landscape it a it even the after relates as ingredients very additive and opportunities a both number certain lends lot attractive

even sheet enterprises be go shake companies of to U.S. hard you entity centric maybe It that might M&A still, out you return it you do do you may are or XX XX to you the your may in that multiples these have months to somewhat look broadened revisit given you see is capital place. of out be want looking product of size you the that? your because and ability where of get to or think still aim next are all Do might just existing selective parts some can your characteristics challenging done that you of you be stay kind at just Now maybe do hard or over talk shareholder still kind very be deals Thank larger to sense buy I with to and Have loose. which filter and you. of filter to and you there you an about at? otherwise. get a balance broadened But ways that with M&A your might

lot a there. Brett; question Great in

capital You deployment strategy know our unchanged. remains really

the we First we QX. trying organic growth with drive quite delivered we are and foremost, are and growth to in organic pleased

our in are with manufacturing need investments to say time XXXX. – we in are and last up are little to our our We strategically M&A went based also have acquisitions, up R&D a see but cash do really focus reform. though that. of the of ones on would size But couple access that, ramping ramping more we smart significantly that spend maybe we investments company capabilities our talking to and investing significant thirdly, you medium three, They are the made I and continue then to value significant through we been of but And Bill pretty capital financially, that beneficial in we where on our about accretive problem. in tax do good both return as lot we have company. for been now so and small very bit never for years company, one access our very, the has a have benefits two to feel and fundamentally

capabilities. borrowing good have We

want very chaining be there. about I fundamentally So think it. disciplined our strategy to We not is

have not last at, the for for go larger bolt-on at It’s the able the doable we Geographic of defiantly get partly so that We ones that forth. bolt-on’s. happen acquisitions to always are we followed to as these acquisitions. more available and are look and these just in couple us. a those smaller expansion it’s do do is years, But sizable what’s line as appetite filter well so an explore, be we were across looking

and and think interested into fit are expanding those probably capabilities the our because about in those infrastructure We of company we’ve our technologies are take said existing filter some us focus international we we and I markets. so a some Adjacent their excitement for definitely to last think products Primarily in products to time. got really and broadening as having internally. markets that

product the as leg stool, really potentially adjacent for well fifth are as expansion. the to geographic any necessarily markets, diversification We kind, more around of its know applications, you not looking submarkets

much. Thank you so

Thanks Brett.

Instructions]. [Operator

Our Khorsand your Please question. question BWS Hamed of next Financial. line comes from of with the proceed

regulatory just margins? about just I if there any had for is Could you. Is question Hi. you really the that one substation talk your that solution more process? to or manage into

you sort sorry, in as sort or… mind I’m would of which market substitution on elaborating of

that are process material going there’s I’m raw going just ability hinders these of any material materials to some that your trying substitute about approval talking a that. up, ask up are you cost. regulatory if costs to if raw it’s Sure, and

Right.

take fairly out is I you our would it’s with In and our customer, It’s say no we something speaking for But so it an to may source do know So say substitute but of generally use and In that there opportunity, we have our across is essentially or limited. lot can raw be some really business something choline the ability way different could we our different would customer and it’s materials. in be process, typically a ingredient. would don’t some a approval to we not a I there time. use there quickly. there other business but is generally whole do do ingredient its and some a to label company protein going food really speaking, different collaboration flexibility where change

you. Thank okay. it, Got

you. Thank

from Tony Aegis of comes question. with Polak Capital. question next your the of line Our proceed Please

R&D, capital us and Could morning. for little are what you anything months more three a the give on clarity expenditure the you Good on? on spending money increase

hey Sure, Tony.

around guided for had million. know million; million expenditures And million. million were think $XX to the and $XX.X came $XX.X for we I think around I’m You $X.X capital QX sorry year I we $XX in

expenditure we and Utah came the our where closed. our particular normal projects just thought as increase that in we had finished bit earlier a was Ogden, kind in a new the little the but sight year, I big project QX. associated with close of than and closed when in that than would to XXXX and caused was say was really and capital of little biggest In So pretty QX we a that fire timing Clearfield facility higher and for expected originally building

tend in was came R&D to dollars a Nutrition Human & spend QX clinical as to to most Health we about almost externally again, do field we business, where and spend its So the work, would as for Nutrition as trials business. of we We much our and the Animal on higher. tend and year. well little bit so Health Relative whether as we we R&D, internally thought the forth.

the that Biomarker human help For of efforts to believe could for example, I were be mentioned space, nutrition in a deeply we today Choline the Choline. if that very growth significantly developed

dollars in a So $X.X ultimately grant. of this than that little spending we resulted of funded a know less hundred think North and Carolina, the small million study I thousand you couple University pilot at

very felt spend substantive money a really bit were project that and little a to most that’s we pleased important strategic here to able we funding ultimately get of much us. So a for

I But quite So generation that – think to the that would their money encapsulated Nutrition say do team I are on expertise that’s a kind members and Albion bit some our R&D next efforts and in space. their our the portfolio products. have of joint addition honestly Human increasing spending and spending the Balchem of really we propelled we of

money are a Choline. investment. and Those really external our of and combination areas of are enhanced spending biggest handing internal and We it’s two properties on

a have or you in Do XXXX that number spent R&D you for quarter? fourth the Okay. in

that I exact don’t have number.

full the Tony, Bill. million year. $X.X its Its for

you. thank Okay,

Thanks Tony.

audio over closing conference. remarks. over like the the the and Mr. the of There Chairman CEO further portion questions conference President Board, back will for no now Harris, to of turn to I are Ted

wrap-up to for our call and Thanks. our company. say continued again your just joining in I you want and thank just interest

momentum and results QX our with pleased very the are XXXX. we We have into going

Minneapolis we’ll several XX, hope then speaking to you see Canaccord May. We and early in attending some other by so or you those we next with shows week events and road at events Sidoti non-deal New and we hosted York our to in and look March week Milwaukee with there have that on at certainly in the next Boston forward of call

call. today’s joining for again thanks So

This concludes your conference. for you participation. today’s Thank

your and rest may day. lines You of disconnect at your this time a have wonderful